Sub menu

 
 

Reclassification of medical devices that administer medicines or biologicals by inhalation

Updated guidance to reflect new amendments made to the regulations.

Last updated

This guidance aims to assist sponsors of medical devices that administer medicines or biologicals by inhalation with meeting their obligations and outlines transitional arrangements to help comply with new regulations.

From 25 November 2021 medical devices that administer medicines or biologicals by inhalation will be required to meet regulatory requirements demonstrating the safety and efficacy of the product commensurate with the higher classification (Class IIa or Class IIb).

  • About this guidance
  • Medical devices that administer medicines or biologicals by inhalation
  • What you need to do
  • Notifying the TGA
  • Application to transition
  • If your inclusion application is not successful
  • When to cease supply using your old ARTG entry

Supporting documents

Topics

Help us improve the Therapeutic Goods Administration site